Yangxin Fu

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 26 publications

KAT6B/A::KANSL1 uterine sarcoma - A case with recurrences following uterine morcellation and the development of primary cell line model.

KAT6B/A::KANSL1 uterine sarcoma - A case with recurrences following uterine morcellation and the development of primary cell line model.

Journal: Gynecologic oncology reports

Published: June 01, 2026

Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.

Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.

Journal: The Journal of pathology

Published: November 25, 2025

Ferroptosis as a novel targeted therapy in gynecological malignant tumors.

Ferroptosis as a novel targeted therapy in gynecological malignant tumors.

Journal: Discover oncology

Published: November 24, 2025

Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations.

Establishment and characterization of preclinical models of human gynecologic tract carcinosarcomas demonstrates targetable FGFR1 alterations.

Journal: Translational oncology

Published: August 28, 2025

Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.

Preclinical 3D model screening reveals digoxin as an effective therapy for a rare and aggressive type of endometrial cancer.

Journal: Gynecologic oncology

Published: March 28, 2024

Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer.

Targeted proteomics of plasma extracellular vesicles uncovers MUC1 as combinatorial biomarker for the early detection of high-grade serous ovarian cancer.

Journal: Journal of ovarian research

Published: March 22, 2024

Chelerythrine induces apoptosis and ferroptosis through Nrf2 in ovarian cancer cells.

Chelerythrine induces apoptosis and ferroptosis through Nrf2 in ovarian cancer cells.

Journal: Cellular and molecular biology (Noisy-le-Grand, France)

Published: December 22, 2023

Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.

Survey of NF1 inactivation by surrogate immunohistochemistry in ovarian carcinomas.

Journal: Gynecologic oncology

Published: August 15, 2023

Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.

Establishment and validation of preclinical models of SMARCA4-inactivated and ARID1A/ARID1B co-inactivated dedifferentiated endometrial carcinoma.

Journal: Gynecologic oncology

Published: June 08, 2023

Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer.

Transcription factor ZIC2 regulates the tumorigenic phenotypes associated with both bulk and cancer stem cells in epithelial ovarian cancer.

Journal: Oncogene

Published: April 01, 2023

RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma.

RNA cytosine methyltransferase NSUN5 promotes protein synthesis and tumorigenic phenotypes in glioblastoma.

Journal: Molecular oncology

Published: July 15, 2022

Characterization of ovarian cancer-derived extracellular vesicles by surface-enhanced Raman spectroscopy.

Characterization of ovarian cancer-derived extracellular vesicles by surface-enhanced Raman spectroscopy.

Journal: The Analyst

Published: October 29, 2021

Showing 1-12 of 26

Last Updated: 09/26/2026